SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-015184
Filing Date
2024-02-14
Accepted
2024-02-14 16:00:12
Documents
1
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5153
  Complete submission text file 0000950170-24-015184.txt   7715
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Pioneering Fund VII, L.P. (Reporting) CIK: 0001805916 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39941 | Film No.: 24637276

Mailing Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Pioneering Fund VII General Partner LLC (Reporting) CIK: 0001805917 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39941 | Film No.: 24637277